JP2019524763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524763A5 JP2019524763A5 JP2019504849A JP2019504849A JP2019524763A5 JP 2019524763 A5 JP2019524763 A5 JP 2019524763A5 JP 2019504849 A JP2019504849 A JP 2019504849A JP 2019504849 A JP2019504849 A JP 2019504849A JP 2019524763 A5 JP2019524763 A5 JP 2019524763A5
- Authority
- JP
- Japan
- Prior art keywords
- ylmethyl
- pyrazine
- fran
- imidazole
- furan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 cyano, nitro, amino Chemical group 0.000 claims description 169
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 72
- 125000003545 alkoxy group Chemical group 0.000 claims description 48
- 150000001875 compounds Chemical class 0.000 claims description 48
- 125000000217 alkyl group Chemical group 0.000 claims description 41
- 125000003118 aryl group Chemical group 0.000 claims description 41
- 125000001072 heteroaryl group Chemical group 0.000 claims description 41
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims description 28
- 229910052736 halogen Inorganic materials 0.000 claims description 26
- 150000002367 halogens Chemical class 0.000 claims description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims description 26
- 239000001257 hydrogen Substances 0.000 claims description 26
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 25
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 24
- 125000000623 heterocyclic group Chemical group 0.000 claims description 24
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 24
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 22
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 21
- 125000000304 alkynyl group Chemical group 0.000 claims description 18
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 18
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 17
- 125000003342 alkenyl group Chemical group 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 17
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 claims description 16
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 15
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 14
- CUPOOAWTRIURFT-UHFFFAOYSA-N thiophene-2-carbonitrile Chemical compound N#CC1=CC=CS1 CUPOOAWTRIURFT-UHFFFAOYSA-N 0.000 claims description 14
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims description 13
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 12
- 125000003282 alkyl amino group Chemical group 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 108060001084 Luciferase Proteins 0.000 claims description 10
- 239000005089 Luciferase Substances 0.000 claims description 10
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 9
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 9
- 125000001188 haloalkyl group Chemical group 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 8
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 7
- 125000004442 acylamino group Chemical group 0.000 claims description 7
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 7
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims description 7
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 7
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 7
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 7
- 125000001769 aryl amino group Chemical group 0.000 claims description 7
- 125000004104 aryloxy group Chemical group 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 7
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims description 7
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 7
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 7
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 7
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 7
- 150000002576 ketones Chemical class 0.000 claims description 7
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 7
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 claims description 7
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 7
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 6
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 6
- 230000009261 transgenic effect Effects 0.000 claims description 6
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- DWHVZCLBMTZRQM-UHFFFAOYSA-N 2H-pyrazolo[4,3-b]quinoxalin-3-amine Chemical compound C1=CC=CC2=NC3=C(N)NN=C3N=C21 DWHVZCLBMTZRQM-UHFFFAOYSA-N 0.000 claims description 4
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000005605 benzo group Chemical group 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 4
- 125000002619 bicyclic group Chemical group 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 3
- PMSVVUSIPKHUMT-UHFFFAOYSA-N cyanopyrazine Chemical compound N#CC1=CN=CC=N1 PMSVVUSIPKHUMT-UHFFFAOYSA-N 0.000 claims description 3
- 238000004020 luminiscence type Methods 0.000 claims description 3
- 230000001568 sexual effect Effects 0.000 claims description 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 2
- ZYHQGITXIJDDKC-UHFFFAOYSA-N 2-[2-(2-aminophenyl)ethyl]aniline Chemical group NC1=CC=CC=C1CCC1=CC=CC=C1N ZYHQGITXIJDDKC-UHFFFAOYSA-N 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- UZLSJAUHCCPJMC-UHFFFAOYSA-N 2-thiophen-2-yl-1h-imidazole Chemical compound C1=CSC(C=2NC=CN=2)=C1 UZLSJAUHCCPJMC-UHFFFAOYSA-N 0.000 claims description 2
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 2
- GXWNSJYVSIJRLS-UHFFFAOYSA-N 6-bromo-8-methylimidazo[1,2-a]pyrazine Chemical compound CC1=NC(Br)=CN2C=CN=C12 GXWNSJYVSIJRLS-UHFFFAOYSA-N 0.000 claims description 2
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000033 alkoxyamino group Chemical group 0.000 claims description 2
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 150000001345 alkine derivatives Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 0 *C(NC(c1ccccc1)=C(*)N12)=C1N=C(Cc1ccc[o]1)C2=O Chemical compound *C(NC(c1ccccc1)=C(*)N12)=C1N=C(Cc1ccc[o]1)C2=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662367689P | 2016-07-28 | 2016-07-28 | |
| US62/367,689 | 2016-07-28 | ||
| PCT/US2017/044150 WO2018022865A1 (en) | 2016-07-28 | 2017-07-27 | Coelenterazine analogues |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524763A JP2019524763A (ja) | 2019-09-05 |
| JP2019524763A5 true JP2019524763A5 (https=) | 2020-09-03 |
| JP7212612B2 JP7212612B2 (ja) | 2023-01-25 |
Family
ID=59558505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019504849A Active JP7212612B2 (ja) | 2016-07-28 | 2017-07-27 | セレンテラジン類縁体 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US10000500B2 (https=) |
| EP (1) | EP3490991B1 (https=) |
| JP (1) | JP7212612B2 (https=) |
| DK (1) | DK3490991T3 (https=) |
| WO (1) | WO2018022865A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10577370B2 (en) * | 2016-12-01 | 2020-03-03 | Promega Corporation | Cell impermeable coelenterazine analogues |
| JP7036343B2 (ja) * | 2017-03-28 | 2022-03-15 | 国立大学法人電気通信大学 | 新規セレンテラジン誘導体 |
| EP3395803A1 (en) * | 2017-04-28 | 2018-10-31 | Institut Pasteur | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins |
| JP7419260B2 (ja) | 2018-05-01 | 2024-01-22 | プロメガ コーポレイション | ＮａｎｏＬｕｃ自殺基質としてのセレンテラジン化合物 |
| TW202021969A (zh) * | 2018-05-31 | 2020-06-16 | 南韓商Ｃ＆Ｃ新藥研究所 | 雜環衍生物及其用途 |
| JP7653351B2 (ja) * | 2018-08-23 | 2025-03-28 | プロメガ コーポレイション | セレンテラジン類似体 |
| CN112996923B (zh) | 2018-10-03 | 2025-02-18 | 普洛麦格公司 | 用于稳定腔肠素及其类似物和衍生物的组合物和方法 |
| KR20220121816A (ko) | 2019-11-27 | 2022-09-01 | 프로메가 코포레이션 | 다분할 루시퍼라제 펩타이드 및 폴리펩타이드 |
| CN111072669B (zh) * | 2019-12-03 | 2021-03-26 | 山东大学 | 一种苯基咪唑并吡嗪酮类化合物及制备方法与应用 |
| CN111116594B (zh) * | 2019-12-03 | 2021-05-28 | 山东大学 | 一种C-6位改造NanoLuc类型类似物及其制备方法与应用 |
| US12061202B2 (en) | 2019-12-10 | 2024-08-13 | Promega Corporation | Compositions and methods for bioluminescent detection using multifunctional probes |
| JP7677997B2 (ja) | 2020-05-22 | 2025-05-15 | プロメガ コーポレイション | キナーゼターゲットエンゲージメントの増強 |
| CN116391129A (zh) | 2020-08-28 | 2023-07-04 | 普罗美加公司 | 针对ras蛋白的靶标接合测定法 |
| EP4337646A4 (en) | 2021-05-13 | 2025-05-21 | Promega Corporation | BIOLUMINESCENT DETECTION OF DNA SYNTHESIS |
| JP2023126161A (ja) * | 2022-02-28 | 2023-09-07 | 国立大学法人電気通信大学 | 新規セレンテラジン誘導体 |
| WO2025137564A1 (en) * | 2023-12-20 | 2025-06-26 | Promega Corporation | Coelenterazine analogues |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007096764A2 (en) | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
| US20090075309A1 (en) | 2007-09-06 | 2009-03-19 | Gambhir Sanjiv S | Bisdeoxycoelenterazine derivatives, methods of use, and BRET2 systems |
| JP5353279B2 (ja) | 2009-02-06 | 2013-11-27 | Ｊｎｃ株式会社 | セレンテラミド又はその類縁体の製造方法 |
| WO2010090318A1 (ja) | 2009-02-09 | 2010-08-12 | チッソ株式会社 | セレンテラミド類縁体 |
| GB2479847B (en) | 2009-02-09 | 2014-02-19 | Jnc Corp | Coelenterazine analogs and manufacturing method thereof |
| WO2010121003A1 (en) | 2009-04-16 | 2010-10-21 | Mallinckrodt Inc. | Pyrazine derivatives for optical imaging and therapy |
| EP2454261B1 (en) | 2009-07-13 | 2014-11-19 | Universita Degli Studi di Siena | Imidazo[1,2-alpha]pyrazin-3(7h)-one derivatives bearing a new electron-rich structure |
| JP5605727B2 (ja) | 2010-04-06 | 2014-10-15 | Ｊｎｃ株式会社 | セレンテラジン類縁体及びセレンテラミド類縁体 |
| WO2012040105A2 (en) | 2010-09-21 | 2012-03-29 | Kansas State University Research Foundation | Renilla/gaussia transfected cells as a light source for in-situ photodynamic therapy of cancer |
| WO2012061477A1 (en) | 2010-11-02 | 2012-05-10 | Promega Corporation | Coelenterazine derivatives and methods of using same |
| BR112013010487B1 (pt) * | 2010-11-02 | 2021-02-02 | Promega Corporation | compostos de coelenterazina, kit compreendendo ditos compostos e método para detectar luminescência em uma amostra in vitro |
| JP5637907B2 (ja) | 2011-03-08 | 2014-12-10 | Jnc株式会社 | ｖ−セレンテラジン化合物の製造方法 |
| US8785652B2 (en) | 2011-08-16 | 2014-07-22 | Promega Corporation | Detection of hydrogen peroxide |
| WO2014145512A2 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Potent small molecule inhibitors of autophagy, and methods of use thereof |
| JP6040846B2 (ja) | 2013-04-08 | 2016-12-07 | Jnc株式会社 | セレンテラジン類縁体 |
| EP3416968B1 (en) | 2016-02-15 | 2022-07-27 | Promega Corporation | Coelenterazine analogues |
-
2017
- 2017-07-27 JP JP2019504849A patent/JP7212612B2/ja active Active
- 2017-07-27 DK DK17749304.6T patent/DK3490991T3/da active
- 2017-07-27 US US15/661,582 patent/US10000500B2/en active Active
- 2017-07-27 WO PCT/US2017/044150 patent/WO2018022865A1/en not_active Ceased
- 2017-07-27 EP EP17749304.6A patent/EP3490991B1/en active Active
-
2018
- 2018-05-17 US US15/982,514 patent/US10428075B2/en active Active
-
2019
- 2019-08-20 US US16/545,903 patent/US10669280B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019524763A5 (https=) | ||
| Norman et al. | Structure− activity relationships of a series of pyrrolo [3, 2-d] pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists | |
| KR101404290B1 (ko) | 과다-증식성 장애 및 맥관형성과 관련된 질환을 치료하는데유용한 치환된 4-아미노-피롤로트리아진 유도체 | |
| KR101720824B1 (ko) | 카테콜 ｏ-메틸 트랜스퍼라제의 억제제 및 정신병적 장애의 치료에서의 그의 용도 | |
| JP4524072B2 (ja) | 新規化合物 | |
| JP6063870B2 (ja) | ＲＯＲγ活性の阻害用のＮ−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療 | |
| JP2017510576A5 (https=) | ||
| JP2022535227A (ja) | Ｄｎａポリメラーゼシータ阻害剤としてのチアジアゾリル誘導体 | |
| JP2021042230A (ja) | アザベンズイミダゾール及びａｍａｐ受容体調節因子としてのその使用 | |
| JP2013515032A5 (https=) | ||
| TW200524928A (en) | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases | |
| PE20061442A1 (es) | Heterociclicos como agonistas del receptor de acido nicotinico para el tratamiento de dislipidemia | |
| JP2007532580A5 (https=) | ||
| EP2920177A1 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| JP2018525375A5 (https=) | ||
| US7550480B2 (en) | Compounds | |
| BRPI0609719A2 (pt) | derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2, bem como processo para a preparação, composição farmacêutica e emprego dos mesmos | |
| JP2016538316A5 (https=) | ||
| JP2020510092A5 (https=) | ||
| CN106132956A (zh) | 一类杂环化合物、其制备方法和用途 | |
| JP2006506352A5 (https=) | ||
| JP2013519724A5 (https=) | ||
| AU2015349866A1 (en) | 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of GPR139 | |
| JP2016522231A5 (https=) | ||
| PE20120900A1 (es) | Compuestos heterociclicos de fenoximetilo |